Aristotle Capital Boston, LLC Pet Iq, Inc. Transaction History
Aristotle Capital Boston, LLC
- $2.93 Billion
- Q3 2024
A detailed history of Aristotle Capital Boston, LLC transactions in Pet Iq, Inc. stock. As of the latest transaction made, Aristotle Capital Boston, LLC holds 37,486 shares of PETQ stock, worth $1.16 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
37,486
Previous 1,232,590
96.96%
Holding current value
$1.16 Million
Previous $27.2 Million
95.76%
% of portfolio
0.04%
Previous 0.94%
Shares
14 transactions
Others Institutions Holding PETQ
# of Institutions
190Shares Held
30.1MCall Options Held
81KPut Options Held
113K-
Black Rock Inc. New York, NY3.01MShares$93.2 Million0.0% of portfolio
-
Glazer Capital, LLC New York, NY2.19MShares$67.8 Million3.93% of portfolio
-
Eos Management, L.P.1.97MShares$61.1 Million21.45% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.56MShares$48.3 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY1.19MShares$36.8 Million0.03% of portfolio
About PetIQ, Inc.
- Ticker PETQ
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 29,312,800
- Market Cap $908M
- Description
- PetIQ, Inc. operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which include flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medicat...